Results 201 to 210 of about 35,271 (283)

Prevalence and Types of Chronic Pain among Insured Individuals with Tic Disorders. [PDF]

Mov Disord Clin Pract
Ogunsola HY, Bohm MK, Newsome K, Jimenez-Shahed J, Bitsko RH.   +4 more
europepmc   +1 more source

Tic Disorders Care Gaps in Spanish-Speaking Latin America. [PDF]

Mov Disord Clin Pract
Escobar AM, Munoz D, Gautreau S, Rossi M, Pringsheim T.   +4 more
europepmc   +1 more source

Role of glutathione and cysteine in acrylamide metabolism during in vitro and in vivo digestion

Journal of the Science of Food and Agriculture, Volume 106, Issue 8, Page 5012-5020, June 2026.
Abstract Background Acrylamide, a probable human carcinogen found in thermally processed potato products, is reactive towards amino and thiol compounds. This reactivity suggests acrylamide might react with them in the gastrointestinal tract resulting in mitigation of associated risk with acrylamide.
Burçe Ataç Mogol, Choong‐In Yun, Aytül Hamzalıoğlu, Selin Çakmak, Yeşim Şensoy, Nazmiye Çitler, Eunjung Lee, Shin Young Park, Junwon Byun, Young‐Jun Kim, Sanguine Byun, Vural Gökmen   +11 more
wiley   +1 more source

Progress in research on nutrition, neuroinflammation and dopaminergic alterations in Tic disorders. [PDF]

Front Pediatr
Bai L, Jin M, Zhang Q, Sun S.
europepmc   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1399-1417, June 2026.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Subtypes of tic disorders in children and adolescents: based on clinical characteristics. [PDF]

BMC Pediatr
Yang K, Zhang W, Li Y, Wang X, Jiang Z, Hu S, Jun J, Yang Q, Li J, Hong X, Cui Y, Lei T.   +11 more
europepmc   +1 more source

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1374-1382, June 2026.
Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra, Stanislaw Szlufik, Chao‐Kai Hu, Alexandre Boutet, Jürgen Germann, Andres M. Lozano   +5 more
wiley   +1 more source

Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders. [PDF]

BMC Pediatr
Xin Y, Gao L, Li S, Wang J, Chen C, Tuo Y, Nie G, Li R, Sun D, Fu Y, Wang Y, Liu Z.   +11 more
europepmc   +1 more source

Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1427-1434, June 2026.
Abstract Background Effective drug treatment of motor and non‐motor symptoms in Parkinson's disease (PD) often requires the administration of several anti‐Parkinson drugs in complex treatment regimens. The successful autonomous application of drugs places high demands on therapy adherence, which in turn relies on sufficient medication knowledge ...
Stephan Greten, Sarana Ulaganathan, Johannes Heck, Lan Ye, Matthias Höllerhage, Christoph Schrader, Corinna Ziemann, Olaf Krause, Florian Wegner, Martin Klietz   +9 more
wiley   +1 more source

Clinical characteristics and pharmacotherapy choices in children newly diagnosed with tic disorders in China: a retrospective cohort study. [PDF]

BMJ Paediatr Open
Xiang Y, Tong C, Lu Q, Sun D, Liu Z.
europepmc   +1 more source